• Free Trial
  • Audio & Video Podcasts
  • Trade Policy
  • Press Releases
  • Events
  • Contact Us
  • WisPolitics
Search
Tuesday, November 17, 2026
  • Home
WisBusiness.com WisBusiness
WisBusiness.com WisBusiness.com
  • Free Trial
  • Audio & Video Podcasts
  • Trade Policy
  • Press Releases
  • Events
  • Contact Us
  • WisPolitics
Home PRESS RELEASES Canopus BioPharma Strengthens Its CB1400 Platform Technology for Mucositis and Oncology Treatments...

Canopus BioPharma Strengthens Its CB1400 Platform Technology for Mucositis and Oncology Treatments Through License Agreement with Wisconsin Alumni Research Foundation

June 18, 2008
http://www.businesswire.com/news/home/20080618005636/en
Facebook
Twitter
Google+
Pinterest
WhatsApp

    RELATED ARTICLESMORE FROM AUTHOR

    Fox Cities Chamber: 2026 Octoberfest Weekend gives a $42 million bump to Fox Cities nonprofits and local businesses

    Dane County Farmers’ Market: Holiday Markets begin November 21 at Monona Terrace

    WS Development: Hilldale welcomes the holiday season with annual North Pole Party

    - Advertisement -

    For questions or assistance, please contact: Colin Schmies at schmies@wispolitics.com or 608-206-0476

    WisBusiness.com
    • Subscribe
    • Advertise
    • Press Releases
    • Audio & Video Podcasts
    • RSS
    ©2026 WisBusiness.com All rights reserved.
    Edit with Live CSS
    Save
    Write CSS OR LESS and hit save. CTRL + SPACE for auto-complete.